Inhibition of transcription factor Nrf2 and silencing of p62 were found to sensitize head and neck cancer cells to GPX4 inhibitors, thus inducing ferroptosis and providing a potential treatment to overcome chemoresistance (Shin et al., 2018). This evidence concerns the gene GPX4 and head and neck cancer.